Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Germicidal UV-C System Kills Airborne Pathogens

By HospiMedica International staff writers
Posted on 25 Nov 2020
Rarified-environment technology uses ultraviolet (UV)-C light to kill 99.99% of airborne pathogens, creating ultraclean environments.

The NoviSphere (Elk Grove Village, IL, USA) PE 254 is a cost-effective, high-performance UV pathogen-eradication system that uses fully contained and sealed 254nm UV-C lamps and proprietary baffling technology to kill up to 99.99% of airborne viruses, bacteria, and mold spores. More...
Extensive independent testing has confirmed it also eradicates 99.99% of an aerosol coronavirus strain (HuCov229E), a single-stranded RNA virus that is similar to the COVID-19 strain that causes respiratory illnesses in humans. Further testing is planned to verify 99.9999999% eradication (one part per billion).

The system removes all pathogens in the air, as well as other contaminants, via a variable speed control, that continuously provides up to four complete air changes per hour in a room of an average size. The compact system can be used in virtually any large public setting, including (but not limited to), hospitals, schools, warehouses, manufacturing plants, hospitality, mass transit centers, sports facilities, and a range of industrial and commercial settings.

“At NoviSphere, our mission is to deliver confidence and safety to customers in their communities, workplaces, and businesses. Rarified environments we enable through our technologies are pathogen and particulate free; essentially, a magnitude better than today’s stringent ultraclean standards,” said Paul Lockhart, CEO of NoviSphere. “As a former astronaut entrusted with some of our nation’s most critical assets, I can think of no endeavor more important than what we are embarking on at NoviSphere.”

“Published papers in Aerosol Science & Technology show it is particularly effective against single-stranded RNA viruses,” said Chris Hogan, PhD, of the department of mechanical engineering at the University of Minnesota (Minneapolis, USA), who conducted the testing. “Coronaviruses, and more specifically, SARS-CoV-2, are single-stranded RNA viruses and would be highly susceptible to UV-C activation. Sealed, ducted UV-C sources with flow rates above 10 CFM are an effective approach.”

UVC light in the 254 nm wavelength induces the formation of pyrimidine dimmers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, destroying the organisms or rendering them unable to reproduce. Intense UV-C light also has a proven track record of virus inactivation in aerosols.

Related Links:
NoviSphere


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.